Hood River Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.7M | Buy |
+371,104
| New | +$38.7M | 0.54% | 65 |
|
|
2025
Q1 | – | Sell |
-644,785
| Closed | -$54.6M | – | 147 |
|
|
2024
Q4 | $54.6M | Buy |
644,785
+19,701
| +3% | +$1.67M | 0.81% | 45 |
|
|
2024
Q3 | $56.2M | Buy |
625,084
+76,018
| +14% | +$6.83M | 0.91% | 42 |
|
|
2024
Q2 | $44.2M | Buy |
549,066
+28,316
| +5% | +$2.28M | 0.92% | 38 |
|
|
2024
Q1 | $41.6M | Buy |
520,750
+127,997
| +33% | +$10.2M | 0.93% | 39 |
|
|
2023
Q4 | $31.3M | Buy |
392,753
+9,477
| +2% | +$754K | 0.86% | 46 |
|
|
2023
Q3 | $26.8M | Sell |
383,276
-1,085
| -0.3% | -$75.8K | 0.86% | 51 |
|
|
2023
Q2 | $27.6M | Buy |
384,361
+3,539
| +0.9% | +$254K | 0.82% | 55 |
|
|
2023
Q1 | $23.5M | Sell |
380,822
-79,473
| -17% | -$4.9M | 0.76% | 51 |
|
|
2022
Q4 | $35.5M | Buy |
+460,295
| New | +$35.5M | 1.29% | 29 |
|